Endomorphin-1, an endogenous mu-opioid receptor agonist, improves apomorphine-induced impairment of prepulse inhibition in mice (Q44342424)

2 December 2017

title

Endomorphin-1, an endogenous mu-opioid receptor agonist, improves apomorphine-induced impairment of prepulse inhibition in mice (English)

1 reference

2 December 2017

0 references

Makoto Ukai

1

1 reference

2 December 2017

Ami Okuda

series ordinal

2

1 reference

2 December 2017

publication date

1 May 2003

1 reference

2 December 2017

number of pages

4

1 reference

inferred from page(s)

published in

Peptides

1 reference

2 December 2017

volume

24

1 reference

2 December 2017

issue

5

1 reference

2 December 2017

page(s)

741-744

1 reference

Endomorphins have orexigenic and anxiolytic activities in mice

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900123-2

7 January 2021

Sensorimotor gating and schizophrenia. Human and animal model studies

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900123-2

7 January 2021

Gating and habituation of the startle reflex in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900123-2

7 January 2021

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900123-2

7 January 2021

Naloxonazine actions in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900123-2

7 January 2021

Neuropeptides, dopamine, and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900123-2

7 January 2021

A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900123-2

7 January 2021

Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900123-2

7 January 2021

Combination of a delta opioid receptor agonist but not a mu opioid receptor agonist with the D1-selective dopamine receptor agonist SKF 38393 markedly potentiates different behaviors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900123-2

7 January 2021

[D-Ala2,NMePhe4,Gly-ol5]enkephalin, but not [D-Pen2,L-Pen5]enkephalin, specifically inhibits behaviors induced by the dopamine D2 agonist RU 24213.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900123-2

7 January 2021

Opioid receptor agonists selective for mu and kappa receptors attenuate methamphetamine-induced behavioral sensitization in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900123-2

7 January 2021

Endomorphin-1 improves scopolamine-induced impairment of short-term memory via mu1-opioid receptor in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900123-2

7 January 2021

DAGO ([D-Ala2,N-Me-Phe4,Gly-ol]enkephalin) specifically reverses apomorphine-induced increase in rearing and grooming behaviors in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900123-2

7 January 2021

Receptor-selective opioid peptides fail to affect behavioral responses induced by a low dose of apomorphine in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900123-2

7 January 2021

Effects of endomorphins-1 and -2, endogenous mu-opioid receptor agonists, on spontaneous alternation performance in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900123-2

7 January 2021

Endomorphins 1 and 2, endogenous mu-opioid receptor agonists, impair passive avoidance learning in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900123-2

7 January 2021

A potent and selective endogenous agonist for the mu-opiate receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900123-2

7 January 2021

10.1016/S0196-9781(03)00123-2

Identifiers

DOI

1 reference

2 December 2017

1 reference